৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Rosutin EZ Tablet, a combination of Rosuvastatin (an HMG-CoA reductase inhibitor) and Ezetimibe (a cholesterol absorption inhibitor), is indicated in adults:
Rosuvastatin reduces plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. It increases the number of hepatic LDL receptors on the liver cell surface, thereby enhancing the uptake and catabolism of LDL cholesterol. Rosuvastatin also reduces LDL production and the number of circulating LDL particles.
Ezetimibe lowers blood cholesterol by inhibiting the absorption of cholesterol from the small intestine. Its molecular target is the sterol transporter involved in the intestinal uptake of cholesterol and phytosterols, thereby reducing the delivery of intestinal cholesterol to the liver.
(Not on haemodialysis)
Safety and effectiveness have not been established in paediatric patients.
No dosage adjustment is required for elderly patients.
Concomitant use with the following drugs is not recommended:
Dosage modification may be required in patients receiving:
The following medications may increase the risk of myopathy and rhabdomyolysis when used concomitantly:
Rosutin EZ Tablet is contraindicated in patients with:
Common adverse effects include:



Drug Class
Combination of a statin (Rosuvastatin) and a cholesterol absorption inhibitor (Ezetimibe).
Belongs to the class of lipid-lowering agents.
Purpose
Used to treat hyperlipidemia (high cholesterol).
Helps reduce LDL cholesterol (“bad cholesterol”) more effectively than either drug alone.
Prescribed to lower the risk of heart attack, stroke, and other cardiovascular diseases.
Mechanism
Rosuvastatin: Blocks HMG-CoA reductase in the liver, reducing cholesterol production.
Ezetimibe: Prevents absorption of cholesterol from the intestine.
Together, they provide dual action—less cholesterol made in the liver and less absorbed from food.
Advantages
Stronger LDL reduction: More effective than statin alone.
Convenient combination: Two medicines in one tablet reduce pill burden.
Cardiovascular protection: Helps prevent complications in patients with high cholesterol or existing heart disease.
Well tolerated: Generally safe with proper monitoring.
Dose:
Commonly available as Rosuvastatin (5–20 mg) + Ezetimibe (10 mg) tablets.
Usual dose: Once daily, taken with or without food.
Exact dosage must be prescribed by a doctor depending on cholesterol levels and patient condition.
Stronger LDL reduction: Lowers “bad cholesterol” (LDL) more effectively than statin alone.
Dual mechanism: Rosuvastatin reduces cholesterol production in the liver, while Ezetimibe blocks absorption from food.
Cardiovascular protection: Helps reduce risk of heart attack, stroke, and other complications.
Convenient combination: Two medicines in one tablet, reducing pill burden.
Improves treatment response: Useful for patients who do not reach target cholesterol levels with statin alone.
Well tolerated: Generally safe with proper monitoring of liver function and muscle health.





